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Introduction
The 18S, 5.8S, and 28S (25S in yeast) ribosomal RNAs (rRNAs) 
are transcribed as a single precursor by RNA polymerase I in the 
eukaryotic nucleolus. This precursor rRNA (pre-rRNA) under-
goes processing and assembly steps to produce the large (LSU) 
and small (SSH) ribosomal subunits (Henras et al., 2008). 
Ribosome biogenesis requires more than 200 trans-acting factors 
including nucleases, helicases, small nucleolar RNPs, and 80 
ribosomal proteins (Henras et al., 2008). This process consumes 
a large percentage of cellular energy and the rate of ribosome 
biogenesis determines the proliferative potential of the cell 
(Warner, 1999). Ribosome production is regulated in a cell 
cycle–dependent manner being down-regulated during differ-
entiation and up-regulated in cancer. Ribosome biogenesis is 
down-regulated by tumor suppressor p19ARF and plays a di-
rect role in activating the tumor suppressor p53 (Lessard et al., 
2010; Chakraborty et al., 2011). Furthermore, several genetic 
diseases, including cartilage-hair hypoplasia (CHH), alopecia, 
neurological defects, and endocrinopathy syndrome, and Dia-
mond Blackfan anemia, are linked to defects in ribosome pro-
duction (Nousbeck et al., 2008; Narla and Ebert, 2010).
The vast majority of studies of ribosome biogenesis have 
been performed in the yeast Saccharomyces cerevisiae. The 
transcribed spacers are removed by a series of endonucleolytic 
and exonucleolytic processing steps. Key to pre-rRNA process-
ing are the cleavages at sites A2 and A3 in internal transcribed 
spacer 1 (ITS1), which separate the RNAs for the LSU (28S 
and 5.8S) and SSU (18S). Cleavage at site A2, reportedly medi-
ated by Rcl1 (Horn et al., 2011), is linked to the removal of the 
5 external transcribed spacer (ETS) and these processing steps 
are performed by the SSU processome complex (Phipps et al., 
2011). One protein in this complex, Rrp5, is also required for A3 
cleavage (Venema and Tollervey, 1996). After A2 cleavage, the 
remaining 5 region of ITS1 is removed by Nob1 cleavage at site 
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cleavage in the mammalian ITS1 (Mullineux and Lafontaine, 
2012). It has, however, been speculated that the endonucleolytic 
cleavage at site 2a in mammals, which generates 18SE, is equiva-
lent to the A2 cleavage in yeast (Carron et al., 2011; Wang and 
Pestov, 2011). It is also unclear whether site 2 is equivalent to the 
A3 site, which in yeast is cleaved by RNase MRP (Lygerou et al., 
1996). Processing of mammalian 5.8S rRNA, which involves the 
removal of ITS1 sequences from the 5 end, is influenced by 
knockdown of Dicer or Drosha, the endonucleases linked to 
miRNA production, although neither protein appeared important 
for the primary ITS1 cleavages (Liang and Crooke, 2011).
Human ribosome production is coupled to cellular growth 
rate and linked to both cancer and genetic disease (Narla and 
Ebert, 2010). Despite this, several fundamental questions remain 
about the early pre-rRNA processing steps in humans and, in 
particular, the processing pathway and the enzymes involved 
in ITS1 processing need to be determined. To address these 
points, we have systematically analyzed factors linked to ITS1 
processing in human cells.
Results
The cleavage sites in human ITS1
The potential additional step in the 3 processing of the 18S 
rRNA raises several important questions about human ITS1 
processing (Rouquette et al., 2005). In particular, it was suggested 
D at the 3 end of 18S rRNA (Pertschy et al., 2009; Lamanna and 
Karbstein, 2011). Cleavage at A3 is mediated by the RNA–protein 
complex RNase MRP (Lygerou et al., 1996) and also requires 
Nop4 (RBM28 in humans; Bergès et al., 1994; Sun and Woolford, 
1994). The 5 end of 5.8S is generated by the 5 to 3 exonucle-
ases Xrn2/Rat1 and Rrp17 (NOL12 in humans; Petfalski et al., 
1998; Oeffinger et al., 2009) and also requires seven proteins, 
termed the A3 cluster, which includes Erb1 (BOP1 in humans; 
Granneman et al., 2011; Sahasranaman et al., 2011).
Much less is known about pre-rRNA processing in mam-
malian cells than in yeast. Indeed, many of the human pre-rRNA 
cleavage sites have not been clearly mapped and only one enzy-
matic activity has been documented (Mullineux and Lafontaine, 
2012). Although many of the essential ribosome biogenesis fac-
tors characterized to date in yeast can be found in humans little 
has been done to determine whether these proteins perform the 
same functions in humans. Mammalian rRNA processing is pro-
posed to involve alternative processing pathways, an additional 
cleavage site in the 5ETS (A’; Mullineux and Lafontaine, 2012), 
and an additional processing step (21S to 18SE) in the removal of 
ITS1 (Rouquette et al., 2005; Fig. 1, A and B). Both endonucleo-
lytic and exonucleolytic processing pathways have been postu-
lated for 18SE production but no clear data exists for either 
pathway (Carron et al., 2011; Wang and Pestov, 2011). Although 
A2 is the primary cleavage that separates the rRNAs of the SSU 
and LSU in yeast, it would appear that site 2 cleavage is the initial 
Figure 1. Mapping the cleavages in human ITS1. (A) Alternative processing pathways of human rRNA, with the major pathway indicated in black. 
(B) Schematic representations of pre-rRNA intermediates, with the processing/cleavage sites, ETS and ITS, indicated. (C) HeLa cell RNA was separated by 
glyoxal/agarose gel electrophoresis, transferred to nylon membrane, and hybridized with a variety of ITS1/2 probes (indicated at the top of each lane). 
The RNAs detected are indicated on the right. Panels are reproduced in Fig. S1 A. (D) Ratios of the SSU (30S [dark blue] and 21S [light blue]) or LSU (32S 
[light orange] and 12S [dark orange]) precursors to the 45S/47S transcripts were calculated and plotted for each probe (x axis). A schematic representa-
tion of the region from the 3 end of 18S rRNA to the 5 end of 28S is shown. One set of data, which is representative of at least two experiments, is shown. 
(E) RNA was extracted from control HeLa cells and cells depleted of XRN2 by RNAi (indicated above each lane). Equal amounts of RNA were separated 
on an 8% acrylamide/7 M urea gel and analyzed by Northern blotting using the ITS1 6121 probe. “Ladder” indicates a 32P-labeled 100-bp ladder.
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out this step. We therefore depleted ENP1, XRN2, or the exo-
some component RRP6 from HeLa cells using RNAi (Fig. S2 A), 
and then analyzed the levels of rRNA processing intermediates 
by Northern blotting (Fig. 2 A).
As in mouse cells, depletion of XRN2 in HeLa cells 
caused the accumulation of 47S and 30SL5, a 30S precursor with 
an additional 5 fragment of the 5ETS detected if the A’ cleavage 
is affected (Fig. 2 A), relative to the control cells (Fig. 2 B; 
Wang and Pestov, 2011). In addition, a significant increase in 26S 
was seen in some, but not all, experiments, implying that the order 
of cleavages in the 5ETS is altered by depleting XRN2. Repro-
ducible accumulation of 36S pre-rRNA was observed relative to 
control cells (Fig. 2 B, ITS1 probe) as previously reported in 
mouse cells (Wang and Pestov, 2011), indicating increased initial 
cleavage of ITS1 at site 2a before processing at site 2. Notably, 
depletion of XRN2 changed the levels of several pre-rRNA inter-
mediates without significantly slowing down rRNA processing, 
suggesting that only the balance between competing pathways 
is altered. Depletion of ENP1 resulted in increased levels of 21S 
pre-rRNA, the appearance of 21SC, a 3 shortened form of 21S 
(Carron et al., 2011), and significantly decreased 18SE levels 
(Fig. 2 C). Depletion of RRP6 did not alter the accumulation of 
the longer precursors but resulted in a more significant decrease in 
18SE levels and the accumulation of 21SC (Fig. 2, B and C). In ad-
dition, a range of products, seen as a smear, was often observed 
between 21S and 18SE, indicating inefficient exonucleolytic 
processing of 21S pre-rRNA. Codepletion of RRP6 and ENP1 
resulted in stronger accumulation of 21SC and more signifi-
cant reduction in 21S and 18SE than either single knockdown 
(Fig. 2 C). This indicates that RRP6 functions together with 
certain rRNA processing factors in the processing of ITS1.
We next used metabolic labeling experiments to determine 
the effect of depleting RRP6 on the accumulation of mature 
rRNAs. HeLa cells were transfected with control siRNAs or 
siRNAs targeting the RRP6 mRNA. The cells were metaboli-
cally labeled using 3H methyl-methionine (Fig. 2 D) or 32P 
orthophosphate (Fig. S3, A and B) and harvested at various time 
points after the addition of unlabeled media. Total RNA was 
separated by glyoxal gel electrophoresis, transferred to nylon 
membrane, visualized using a phosphorimager, and quantified.
In control cells, 47S/45S pre-rRNAs were observed at the 
start of the chase (Fig. 2 D). With time, the 32S intermediate accu-
mulated and this was followed by the mature 18S and 28S rRNAs. 
Because of their low relative abundances, the 41S, 30S, and 21S 
pre-rRNAs were barely visible and difficult to follow in these ex-
periments. In both control and knockdown cells, 32S pre-rRNA and 
28S rRNA accumulated at a similar rate and to similar levels. In 
contrast, significantly less 18S rRNA was produced during the time 
course in RRP6-depleted cells (approximately two- to threefold 
less at 3 h relative to 28S levels). We conclude that RRP6 is required 
for the efficient production of the 18S rRNA in human cells and 
that the majority of the SSU rRNA is produced via this pathway.
The exonuclease activity of RRP6 is 
required for 18SE production
To determine whether the exonucleolytic activity of RRP6 
was required for 18SE production, stably transfected HEK293 
that 18SE can be generated by either endonucleolytic or exo-
nucleolytic processing of 21S (Carron et al., 2011). Northern 
blotting was therefore used to recharacterize the pre-rRNA 
intermediates containing ITS1 sequences and better define the 
cleavage sites. HeLa cell RNA was separated by glyoxal gel 
electrophoresis, transferred to nylon membrane, and then hy-
bridized with a variety of probes recognizing ITS1, 5.8S, and 
ITS2. For each probe, the ratio of the smaller RNAs (30S, 32S, 
21S, and 12S) to 45/47S was calculated and plotted.
All of the probes recognized the 47S/45S pre-rRNAs 
(Fig. 1, C and D; and Fig. S1 A). Interestingly, three ITS1 probes 
(6396, 6448, and 6508) failed to detect the smaller pre-rRNAs 
(32S, 30S, 21S, and 12S), suggesting this region is missing from 
both the LSU and SSU precursors. The 30S and 21S precursors 
of 18S rRNA were detected by probes hybridizing between 5520 
and 6318, although weaker signals were reproducibly seen using 
probes between nucleotides 6121 and 6318. The 3 ends of 30S 
and 21S pre-rRNAs are therefore very heterogeneous. The 32S 
and 12S pre-rRNAs were consistently detected using 5.8S and 
ITS2 probes. In contrast, probe 6603, at the 3 end of ITS1, 
only weakly detected 32S and did not recognize 12S (Figs. 1 D 
and S1 A). We conclude that the majority of 32S and all 12S 
pre-rRNAs lack ITS1 sequence, with site 2 cleavage occurring 
in the region between nucleotides 6396 and 6508.
We next investigated whether fragments of ITS1 were 
generated by serial endonucleolytic cleavages. Yeast ITS and 
ETS fragments released by endonuclease cleavage are degraded 
by either the exosome or the 5 to 3 exonuclease Xrn2 (Rat1; 
Petfalski et al., 1998). XRN2 and the exosome component RRP6 
were therefore depleted from HeLa cells using RNAi (Fig. S2 A) 
and the accumulation of ITS1 fragments analyzed by Northern 
blotting. Depletion of XRN2 resulted in the accumulation of an 
800-nt fragment of ITS1 that extended from site 2a to position 
6318 (Fig. 1 E). This fragment was barely detectable in control 
cells and no other fragments were detected after depletion of 
XRN2 and/or RRP6 (unpublished data). This indicated that 
there are two early endonucleolytic cleavages in ITS1 (at sites 2 
and 2a), which together release the 800-nt fragment.
Only a small fraction of the 32S species extended to site 
2, indicating rapid processing to the mature 5 end of 5.8S. In 
yeast, cleavage upstream of 5.8S is very rapidly followed by 5 
to 3 exonucleolytic digestion. Knockdown of XRN2 resulted 
in an increase of 32S containing the 3 end of ITS1, indicating 
that this is also the case in humans (Fig. S1 B). The heterogene-
ity observed in the 3 ends of 30S and 21S suggested that these 
precursors might be processed by 3 to 5 exonucleases acting 
from site 2, in addition to endonucleolytic cleavage at 2a.
RRP6 is required for 18S rRNA 
accumulation in human cells
The accumulation of the 800-nt ITS1 fragment clearly indicates 
that the 18SE precursor can be generated by endonucleolytic 
cleavage at 2a. However, previous analyses after depletion of 
the small subunit biogenesis factor ENP1 indicated that 18SE 
can be produced by both endonucleolytic and exonucleolytic 
processing pathways (Carron et al., 2011). The 3 to 5 exonucleo-
lytic activity of the exosome is a likely candidate for carrying 
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et al., 2011) are required for 18SE accumulation. Individual 
proteins were depleted from HeLa cells using RNAi (Fig. S2 A) 
and the effects on rRNA processing were analyzed. No signifi-
cant changes in the levels of the longer, 47S to 30S, pre-rRNAs 
were seen. Depletion of either RRP46 or the RNA helicase 
MTR4 resulted in a fourfold reduction in 18SE levels (Fig. 3, 
C and D). However, instead of the prominent band of 21SC 
seen when RRP6 was depleted, a broad range of differently 
sized products between 21S and 18SE, often visible as a smear, 
were seen upon depletion of RRP46 or MTR4. Depletion of 
DIS3 or C1D (the human homologue of yeast Rrp47/Lrp1) 
had no clear effect on 21S, 21SC, and 18SE levels, whereas 
depletion of MPP6 resulted in a slight accumulation of 21SC 
but no change in 18SE levels. Each of these proteins were, 
however, essential for 3 processing of 5.8S, as previously re-
ported (Fig. S2 B; Schilders et al., 2007; Tomecki et al., 2010). 
These data suggest that RRP6 acts catalytically in 18SE produc-
tion, functioning together with the exosome core, the MTR4 
helicase, and, to a lesser extent, the exosome cofactor MPP6. 
The lack of effect seen on DIS3 depletion is not entirely un-
expected, as little of the protein is in the nucleolus where this 
processing step is predicted to occur (Tomecki et al., 2010).
The majority of 18SE appears to be generated by exonucleo-
lytic processing of 21S by RRP6 and the exosome core, whereas 
endonucleolytic cleavage at site 2a was only observed after the 
depletion of XRN2. We therefore tested whether stimulation 
of the endonucleolytic pathway by depletion of XRN2 would 
make 18SE production independent of the exosome and MTR4. 
cells were generated expressing either FLAG-tagged RRP6 
or an exonuclease mutant, RRP6exo (Fig. S3, C and D). The 
catalytic site mutation (D313A) abolished exonuclease activ-
ity of recombinant RRP6exo in vitro (Fig. S3 E). The ORFs of 
wild-type and mutant RRP6 were altered to make the mRNAs 
resistant to RNAi-mediated depletion of RRP6 without chang-
ing the coding potential (Fig. S3 F). The cells were trans-
fected with siRNAs targeting endogenous RRP6 and the 
expression of RRP6 was analyzed by Western blotting (Fig. 3 A). 
Control cells, expressing just the FLAG tag and transfected 
with control siRNAs, were also analyzed. After siRNA treatment 
the endogenous protein was no longer detectable, whereas the 
tagged RRP6 and RRP6exo proteins, which because of the pres-
ence of the tag run slower in the SDS gel, were not affected.
HEK293 cells contain higher levels of 47S/45S and 18SE 
than the other precursors relative to HeLa cells, but pre-rRNA 
levels were unaltered by replacement of endogenous RRP6 by 
FLAG-RRP6 (Fig. 3, A and B). In contrast, 18SE levels were 
reduced and both 21S and 21SC levels were increased in cells 
expressing only RRP6exo. This demonstrates that the exonu-
cleolytic activity of RRP6 is required for efficient conversion of 
21S to 18SE.
The exosome core and exosome cofactors 
are required for 18SE production
The exosome is a multi-subunit complex and we assessed whether 
the nuclease DIS3, an exosome core component (RRP46), or 
exosome cofactors (MPP6, C1D, or MTR4; Lykke-Andersen 
Figure 2. RRP6 is required for ITS1 processing. 
(A) Schematic representation of the 47S pre-
rRNA intermediate and relevant pre-rRNAs. 
The relative positions of Northern blot probes 
are indicated. (B and C) RNA was extracted 
from HeLa cells depleted of RRP6, XRN2, or 
ENP1 by RNAi or control cells and analyzed 
by ethidium bromide staining (UV) and North-
ern hybridization using probes specific to the 
5 end and middle of ITS1 as indicated. Po-
sitions of the various intermediates detected 
are indicated. (D) HeLa cells depleted of 
RRP6, or control cells, were pulse labeled with 
3H methyl-methionine followed by incubation in 
normal media for varying lengths of time (indi-
cated above each lane). RNA was recovered 
from the cells, separated using glyoxal/aga-
rose gel electrophoresis, and visualized using 
a phosphorimager and ethidium bromide 
staining (UV). The control data are repeated in 
Fig. 6 E. Black lines in B indicate intervening 
lanes that have been removed.
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and Pestov, 2011). Cleavage at A2 is dependent on factors linked 
to 18S processing, including SSU processome components 
(Henras et al., 2008). We therefore used RNAi to determine 
whether SSU processome proteins (fibrillarin, UTP24, RCL1, 
BMS1, and RRP5) and other 18S rRNA processing factors 
(NOB1, ENP1, and RPS19) are required for ITS1 processing in 
HeLa cells (Fig. S2 A). The requirement of factors for 2a endo-
nucleolytic cleavage cannot readily be assessed because 36S 
pre-rRNA, the only intermediate specific to this pathway, is barely 
detectable in control cells. However, depletion of XRN2 stimu-
lates processing through this pathway, so each knockdown was 
performed both individually and in combination with XRN2 to 
facilitate monitoring of 2a cleavage. Pre-rRNA processing in 
the knockdown cells was followed by Northern blotting (Fig. 4 A) 
and metabolic labeling (Fig. S4).
Depletion of fibrillarin, BMS1, or UTP24 resulted in a 
strong reduction of 41S, 18SE, and 21S and the accumulation of 
30S (Fig. 4 A). Fibrillarin depletion also caused accumulation 
Using RNAi, RRP46 or MTR4 were depleted, alone or together 
with XRN2, and the effect on 18SE production was monitored 
by Northern blotting. As described above, depletion of XRN2 
had no effect on 21S and 18SE levels, whereas depletion of 
RRP46 or MTR4 reduced the levels of 18SE more than fourfold 
(Fig. 3 E). Strikingly, codepletion of XRN2 with either RRP6 or 
MTR4 resulted in almost normal levels (80–90%) of 18SE.
We conclude that depletion of XRN2 favors endonucleo-
lytic cleavage at site 2a before cleavage at site 2, reducing the 
requirement for the normally major pathway of exosome/MTR4 
processing from site 2 to 2a.
Human endonuclease cleavage site 2a is 
analogous to yeast A2
Our data indicate that cleavage at site 2 normally separates the 
human LSU and SSU pre-rRNAs. In yeast, A2 cleavage per-
forms the same function, but this site is putatively suggested to 
be homologous to the human 2a site (Carron et al., 2011; Wang 
Figure 3. The exonuclease activity of RRP6, the exosome core, and the RNA helicase MTR4 are required for 18SE production. (A) HEK293 cells stably trans-
fected with plasmids expressing the FLAG tag alone (pcDNA5), FLAG-RRP6, or FLAG-RRP6exo were transfected with either control siRNAs (C) or siRNAs 
that target the endogenous RRP6 mRNA (6). The FLAG-RRP6 cDNA sequences had been altered to render the mRNA resistant to the RRP6 siRNAs. Levels 
of the endogenous and plasmid-expressed RRP6 were monitored by Western blotting (bottom panels). Levels of pre-rRNAs were analyzed by Northern 
blotting using a probe hybridizing to the 5 end of ITS1. (B) The levels of the pre-rRNA intermediates from A, which is representative of two experiments, 
are plotted. The identity of each peak is indicated. (C) RNA extracted from HeLa cells depleted of exosome or exosome-cofactor proteins (as indicated 
above each lane) by RNAi was analyzed by Northern blotting using a probe specific for the 5 end of ITS1. (D) The levels of the pre-rRNA intermediates 
from C, which is representative of more than three experiments, are plotted for each knockdown (black) and the control (gray). The identity of each peak 
is indicated. (E) RNA extracted from control HeLa cells or HeLa cells depleted of RRP46 or MTR4, alone or together with XRN2 (indicated at top), was 
analyzed by Northern blotting using a probe against the 5 end of ITS1. Positions of the mature and pre-rRNAs are indicated on the left. RNA loading was 
monitored by methylene blue staining of the 18S and 28S rRNAs (MB). In codepletion experiments, the presence (+) or depletion () of XRN2 is indicated. 
Black lines in A, C, and E indicate intervening lanes that have been removed.
o
n
 M
arch 6, 2017
D
ow
nloaded from
 
Published February 25, 2013
JCB • VOLUME 200 • NUMBER 5 • 2013 582
In yeast, Rrp5 is important for both A2 and A3 cleavages 
(Venema and Tollervey, 1996). In HeLa cells, depletion of 
RRP5 led to a major increase in 45S and a reduction in 30S and 
18SE levels (Fig. 4 A). Decreasing RRP5 levels had a greater 
impact on 18SE levels than on 21S, suggesting that it is also 
important for exonucleolytic processing to site 2a. Metabolic 
labeling experiments confirmed that 45S pre-rRNA accumu-
lated in cells depleted of RRP5, whereas maturation to both 18S 
and 28S rRNAs was severely inhibited (Fig. S4). In Northern 
blots, novel bands above both 30S and 21S were also seen, 
which we termed 30SL3 and 21SL3, respectively. The 30SL3 
intermediate, which unfortunately runs at the same position as 
30SL5 and LSU 32S, lacked the 5 end of the 5ETS (present 
in 30SL5; Fig. 4 C). It was not possible map the 3 end of 
30SL5 because of the overlap with the LSU intermediate 32S, 
but 21SL3 contained the 3 end of ITS1 and 5.8S (Fig. 4 B) and 
from this we infer that 30SL3 also includes the complete ITS1 
and 5.8S regions. When RRP5 was codepleted with XRN2, 36S 
pre-rRNA and the ITS1 fragments were not detected. We con-
clude that decreasing the levels of RRP5 significantly affects 
both cleavages in ITS1, with some precursors produced in which 
both ITS1 cleavages are bypassed and cleavage of the primary 
transcript occurs in ITS2. Collectively, these data are consistent 
of 30SL5, the 5 extended form of 30S generated when A’ 
cleavage is blocked. Codepleting each of these proteins with 
XRN2 inhibited 36S production, indicating that they are all re-
quired for 2a cleavage. Decreasing the levels of ENP1, RPS19, 
or RCL1 resulted in reduced 18SE levels. Depletion of ENP1 or 
RPS19 also brought about 21S and 21SC accumulation, and 
RPS19 depletion caused slight accumulation of 30SL5, indi-
cating a mild A’ processing defect. Reducing RCL1 levels re-
sulted in accumulation of 26S and 30S pre-rRNAs. When XRN2 
was also depleted, 36S and ITS1 fragment accumulation was 
abolished in cells depleted for RPS19, but was merely reduced 
in cells where RCL1 or ENP1 had also been depleted. In yeast, 
Nob1 is the 18S rRNA 3 endonuclease (Pertschy et al., 2009; 
Lamanna and Karbstein, 2011). Depletion of NOB1 resulted in 
18SE accumulation (Fig. 4 A) but no other processing defects, 
consistent with a specific, conserved role in cleavage of site 3 
at the 3 end of 18S. In agreement with this, decreased levels 
of NOB1, fibrillarin, BMS1, UTP24, ENP1, RPS19, or RCL1 
resulted in a reduction or complete loss of 18S rRNA produc-
tion in metabolic labeling experiments (Fig. S4 A). Depletion of 
the box C/D small nucleolar RNP protein fibrillarin also re-
duced 28S rRNA production, likely reflecting U8 involvement 
in ITS2 processing (Peculis and Steitz, 1993).
Figure 4. SSU processome components are 
required for endonuclease cleavage at site 2a 
in ITS1. (A) RNA extracted from control HeLa 
cells or cells depleted of ribosome biogenesis 
factors either alone or together with XRN2 
(indicated at top) was analyzed by Northern 
blotting using probes that recognized either 
the middle or 5 end of ITS1 (indicated on the 
right). RNA loading was monitored by methy-
lene blue staining of 18S and 28S rRNAs 
(MB). FIB., fibrillarin. The presence (+) or de-
pletion (–) of XRN2 is indicated at the top of 
the relevant lanes. (B) RNA from control cells 
or cells depleted of RRP5 was analyzed by 
Northern blotting using probes specific for 
the 5ETS and ITS1 as indicated. The positions 
of the mature and pre-rRNAs are indicated. 
(C) Schematic representation of the full-length 
pre-rRNA transcript and relevant pre-rRNAs. 
Positions of Northern probes are indicated. 
Black lines in A and B indicate intervening 
lanes that have been removed.
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processing at the 5 end of 36S. Strikingly, codepletion of 
XRN2 with NOL12 restored 18SE levels to near wild-type 
levels, suggesting that stimulating site 2a cleavage could rescue 
18SE production (Fig. 5 C).
In metabolic labeling experiments, depletion of RBM28 had 
no effect on 18S rRNA accumulation and resulted in only a mild 
decrease in 5.8S and 28S levels with no change in the ratio of 5.8S 
species (Fig. 5, A and B). Depletion of RBM28 resulted in in-
creased levels of 45S, 41S, 36S, and 36SC, whereas 32S and 12S 
levels were slightly reduced. 30S, 21S, and 18SE levels were unaf-
fected (Fig. 5, C and D). Codepletion of RBM28 with XRN2 
caused significantly more 36S to accumulate than when only 
RBM28 levels were reduced. Compared with the yeast homologue 
of RBM28, which is essential for A3 cleavage (Bergès et al., 1994; 
Sun and Woolford, 1994), depletion of the human counterpart only 
slowed down ITS1 processing and, as seen with the depletion of 
XRN2, resulted in an increase in cleavage at site 2a before site 2.
We conclude that site 2 in the human ITS1 is analogous to 
site A3 in the yeast pre-rRNA. Interestingly, our data therefore 
suggest that, in humans, the A3-like cleavage is the primary en-
donucleolytic cleavage that separates the rRNAs of the large 
and small subunits.
Depletion of RNase MRP proteins does not 
affect cleavage in ITS1
In yeast, A3 cleavage is performed by the endonuclease com-
plex RNase MRP (Lygerou et al., 1996). Loss of this complex 
has only a minor effect on pre-rRNA processing and results in 
defective 5 processing of 5.8S (Schmitt and Clayton, 1993). If 
human site 2, which is the major ITS1 processing site, is cleaved 
by RNase MRP, then we would expect that this endonuclease 
is far more important to pre-rRNA processing in humans than 
it is in yeast. The core RNase MRP/RNase P protein POP1, 
which is essential for the accumulation and function of both 
of these RNPs in yeast, was depleted from HeLa cells using 
RNAi, either alone or in combination with XRN2 (Fig. 6 A). 
Depletion of POP1 resulted in a substantial decrease in the 
levels of this protein and a four- to fivefold decrease in RNase 
MRP and P RNA levels (Figs. 6 B and S4 B). Knockdown 
of POP1 also significantly increases the levels of the viperin 
protein (Mattijssen et al., 2011). The viperin mRNA is a target 
for either RNase MRP or RNase P and lack of proteins com-
mon to these endonucleases results in increased expression of 
the viperin protein. Northern analyses showed that depletion of 
POP1 reproducibly resulted in accumulation of pre-tRNAiMet 
(Fig. S4 B), confirming the impaired function of RNase P, 
although this defect was not clearly visible using pulse chase 
labeling (Figs. 6 E and S4 C). A mild increase in mature tRNA 
levels was observed in the POP1-depleted cells, but this was 
substantially less than seen for the precursor. In contrast, de-
pletion of POP1, either alone or together with XRN2, had no 
noticeable effect on the levels of any of the pre-rRNA inter-
mediates or the ratio of 5.8SS and 5.8SL (Fig. 6, C and D; and 
Fig. S4 D). In metabolic labeling experiments the levels of 
the mature rRNAs were also not significantly affected by the 
depletion of POP1 and there was no change in the ratio of 5.8S 
species detected (Figs. 6 E and S4 C).
with the human 2a site being equivalent to the A2 cleavage site 
in yeast. Furthermore, the impairment of cleavage at both ITS1 
sites on depletion of human RRP5 appears analogous to the in-
hibition of both A2 and A3 cleavages after depletion of yeast 
Rrp5 (Venema and Tollervey, 1996).
Depletion of BOP1, RBM28, and NOL12 
impair cleavage at site 2 in ITS1
In yeast, the A3 endonuclease cleavage site is located 3 of site 
A2. This suggested that human site 2 may be equivalent to yeast 
A3. In yeast, A3 cleavage requires Nop4 (Bergès et al., 1994; Sun 
and Woolford, 1994), which is homologous to human RBM28 
(Nousbeck et al., 2008). Subsequent exonucleolytic digestion 
from A3 to the major 5 end of 5.8S rRNA requires factors in-
cluding Erb1 and Rrp17 (Oeffinger et al., 2009; Granneman 
et al., 2011; Sahasranaman et al., 2011), which are homologous 
to human BOP1 (Pestov et al., 2001) and NOL12, respectively. 
RBM28, BOP1, or NOL12 were depleted from HeLa cells 
using RNAi, either alone or in combination with XRN2, to test 
whether human site 2 is analogous to the yeast A3 cleavage. 
The effects on pre-rRNA processing were analyzed by North-
ern blotting and metabolic labeling experiments. Depletion of 
BOP1 resulted in clear defects in 28S and 5.8S accumulation, 
with loss of the normally major, short form of 5.8S rRNA (5.8SS) 
and accumulation of the longer form (5.8SL; Fig. 5, A and B). 
In addition, depletion of BOP1 also resulted in a reduced rate of 
18S production. Interestingly, depletion of XRN2 had no effect 
on the ratio of 5.8S rRNA species (Fig. 5 B). BOP1 depletion 
resulted in reproducible increases in the levels of 47/45S, 41S, 
36S, and 36SC pre-rRNA, a 5 shortened form of 36S (Fig. 5, 
C, E, and F). Conversely, the levels of 32S, 30S, 21S, and 12S 
were reduced, whereas 18SE levels were only mildly affected 
probably because this intermediate can be generated directly by 
2a cleavage. This indicates that processing at site 2a is only 
slowed, whereas site 2 cleavage is more impaired. Consistent 
with this, significantly less of the ITS1 fragment was observed 
after the codepletion of XRN2 (Fig. 5 D). After BOP1 deple-
tion, 36S accumulation was greatly increased by codepletion of 
XRN2. The levels of 36SC pre-rRNA appeared reduced after 
XRN2 was codepleted with BOP1, suggesting that this repre-
sents an intermediate in 5 to 3 exonucleolytic processing of 
36S to 32S pre-rRNA.
Depletion of NOL12 resulted in defects in 28S, 5.8S, and 
18S rRNA production in metabolic labeling experiments, indi-
cating a complete block in ITS1 processing (Fig. 5 A). NOL12 
depletion also increased the levels of 47/45S, 41S, 36S, and 
36SC pre-rRNAs, although the effect on 36S and 36SC was not 
as dramatic as seen after BOP1 depletion (Fig. 5, C and D). The 
levels of 32S, 30S, 21S, 12S, and 18SE were all significantly 
reduced, indicating that processing at both sites 2a and 2 was 
severely impaired. Consistent with this, ITS1 fragment levels 
were significantly reduced upon codepletion of XRN2 (Fig. 5 D). 
After codepletion of XRN2 with NOL12, 36SC levels were de-
creased and 36S accumulation was increased, but not to the extent 
seen in BOP1 and XRN2 codepletions. The presence of more 
36SC than 36S in NOL12-depleted cells suggests that this prob-
able 5 to 3 exonuclease is not required for the exonucleolytic 
o
n
 M
arch 6, 2017
D
ow
nloaded from
 
Published February 25, 2013
JCB • VOLUME 200 • NUMBER 5 • 2013 584
on pre-rRNA processing (Fig. S4, C and D; unpublished data) 
and no greater impact on tRNA processing than the single de-
pletions. Site 2 cleavage plays an important role in human pre-
rRNA processing so the observation that depletion of RNase 
MRP/P proteins by more than 10-fold had no effect on ITS1 
processing therefore questions the role of human RNase MRP 
in ribosome biogenesis.
Discussion
Here we have characterized alternative ITS1 processing path-
ways in human cells. The major pathway involves a single 
endonucleolytic cleavage at site 2 followed by exonucleolytic 
processing to both the 5 end of 5.8S and to site 2a to generate 
the 18SE precursor, which contains 25 nt of ITS1 at the 3 
These results were unexpected and we therefore also 
analyzed the effect of depleting additional RNase MRP/P sub-
units, RPP38 and RPP40. Levels of these proteins were also 
significantly reduced by RNAi treatment and RNase MRP/P 
RNA levels were decreased (Fig. 6, A and B; and Fig. S4 B). 
Depletion of RPP40 and, to a lesser extent, RPP38 also caused 
accumulation of pretRNAiMet, as previously demonstrated for 
RPP38 (Cohen et al., 2003; Fig. S4 B). Interestingly, modest 
increases in mature tRNA levels were also seen upon deple-
tion of these proteins, although we cannot currently explain 
this observation. Consistent with the depletion of POP1, re-
ducing the levels of either RPP38 or RPP40 had no detectable 
effect on pre-rRNA levels or on accumulation of the mature 
rRNAs (Fig. 6, D and E; and Fig. S4, C and D). Simultaneous 
depletion of POP1 and RPP40/RPP38 also had no clear effect 
Figure 5. BOP1, NOL12, and RBM28 are 
required for site 2 cleavage in ITS1. (A and B) 
HeLa cells depleted of BOP1, RBM28, or 
NOL12 using RNAi or control cells were pulse 
labeled with 32P orthophosphate and then in-
cubated with normal media for 3 h. RNA was 
recovered, separated using glyoxal/agarose 
gel electrophoresis (A) or denaturing PAGE 
(B), and visualized using a phosphorimager 
and ethidium bromide staining (UV). Positions 
of the mature and precursor RNAs are in-
dicated on the left. Note that reduced tRNA 
production observed after depletion of BOP1 
and NOL12 was not consistently seen and likely 
reflects the exceptionally strong effect the 
siRNAs had on the cells. (C) RNA extracted 
from control HeLa cells or HeLa cells depleted 
of ribosome biogenesis factors either alone 
or together with XRN2 (indicated at top) was 
analyzed by Northern blotting using probes 
that recognize either ITS2, ITS1, or the 5 end 
of ITS1 (as indicated on the left). RNA load-
ing was monitored by methylene blue staining 
of the mature 18S and 28S rRNAs (MB). In 
codepletion experiments, the presence (+) or 
depletion () of XRN2 is indicated at the top 
of the relevant lanes. (D) The relative intensity 
of the ITS1 fragment is plotted for the XRN2 
and XRN2 double knockdowns (C), which is 
representative of three experiments. (E) The 
relative intensity of the pre-rRNA intermediates 
detected in C, which is representative of three 
experiments, are plotted (black, control; gray, 
knockdown). (F) Schematic representations of 
47S pre-rRNA and relevant pre-rRNAs. Rela-
tive positions of Northern blot probes are indi-
cated. Black lines in A–C indicate intervening 
lanes that have been removed. on
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exosome and the TRAMP component MTR4 are also needed 
for the full activity/processivity of RRP6. The involvement of 
the RNA helicase MTR4 is not surprising given that this region 
of human ITS1 is 800 nt long (compared with 85 nt in 
yeast), 82% GC rich, and highly structured (Fig. S5). The re-
quirement for RPS19, ENP1, RRP5, and RCL1 in this process-
ing step indicates that the exosome also interacts with the SSU 
processome. Depletion of RRP6 severely reduced, but did not 
abolish, 18SE accumulation and 18S rRNA production. This 
may be a result of incomplete depletion of RRP6 but more 
end of 18S rRNA. The final ITS1 sequence is then removed by 
endonucleolytic cleavage at site 3 (Fig. 7). Alternatively, the 
18SE precursor can be generated by endonucleolytic cleavage at 
site 2a. This minor pathway can compensate for a block in 18SE 
production by exonucleolytic processing after site 2 cleavage 
when stimulated by XRN2 depletion.
After cleavage at site 2, RRP6, a 3 to 5 exonuclease 
component of the exosome complex, processes to site 2a. Im-
portantly, the exosome has not been demonstrated to be in-
volved in ITS1 processing before in any organism. The core 
Figure 6. Depleting levels of RNase MRP does not affect human ribosome biogenesis. Protein (A) and MRP RNA (B) levels in HeLa cells depleted of POP1, 
RPP38, or RRP40 using RNAi were analyzed by Western and Northern blotting, respectively. In A, the control in each panel is derived from reprobing the 
same sample. A representative experiment of three is shown. Antibodies or probes used are indicated on the right. Asterisk, nonspecific protein. 7SL RNA 
levels were used as a loading control. The levels of RNase MRP RNA shown in A were quantified and plotted. (C and D) RNA extracted from control HeLa 
cells or HeLa cells that had been depleted of RNase MRP subunits either alone or together with XRN2 (indicated at top) was analyzed by Northern blotting 
using probes that recognize either ITS2, ITS1, or the 5 end of ITS1 (as indicated on the left). RNA loading was monitored by methylene blue staining of the 
mature 18S and 28S rRNAs (MB). In codepletion experiments, the presence (+) or depletion () of XRN2 is indicated at the top. (E) HeLa cells depleted of 
POP1 or RRP40 using RNAi or control cells were pulse labeled with 3H methyl-methionine and then incubated with normal media for varying time-points. 
RNA was recovered from the cells, separated using glyoxal/agarose gel electrophoresis (top) or denaturing PAGE (bottom) and visualized using a phos-
phorimager. Total RNA was visualized by ethidium bromide staining (middle panels). Positions of the mature and precursor RNAs are indicated. 5S rRNA 
is not detected using this method, indicating that it is not methylated. The left three panels of control data are repeated from Fig. 2 D. Black lines in A and 
C indicate intervening lanes that have been removed.
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in the 5 exonucleolytic processing of the 36S precursor to 32S. 
Indeed, in either BOP1 or RBM28 knockdowns, 36S accumula-
tion was increased relative to 36SC by codepletion of XRN2, an 
exonuclease likely to be involved in converting 36S to 32S. In 
yeast, blocking A3 cleavage or subsequent exonucleolytic pro-
cessing from A3 to the 5 end of 5.8S results in loss of 5.8SS and 
accumulation of 5.8SL. Depletion of human BOP1 resulted in 
the accumulation of only 5.8SL, suggesting that this processing 
mechanism is conserved. Similarities and differences between 
the functions of these proteins in humans and yeast are out-
lined in Fig. 7.
The lack of effect of depleting RNase MRP on site 2 
cleavage and the 5 processing of 5.8S was unexpected. The 
decrease in MRP/P protein levels significantly reduced RNase 
MRP/P RNA abundance and both inhibited cleavage of the 
viperin mRNA (Mattijssen et al., 2011) and affected processing 
of tRNAiMet (Fig. S5 A) and tRNATyr (unpublished data). It 
was surprising that the effect on tRNA processing, caused by 
depleting multiple components of the RNase P complex to this 
extent, was not stronger. These data are, however, consistent 
with previously published data analyzing RPP38 (Cohen et al., 
2003). Indeed, the authors claimed that RPP38 is not essential 
for pre-rRNA processing after only observing very weak accu-
mulation of 5.8S processing intermediates. We did not observe 
the accumulation of such precursors in RPP38, POP1, or RPP40 
knockdowns (Fig. S5). As a result of the nature of RNAi knock-
downs, low residual levels of proteins remained after depletion 
of RPP40, RPP38, or POP1 (<10% of each). In consequence, 
we cannot exclude the possibility that the residual RNase MRP 
activity is sufficient to maintain pre-rRNA processing. How-
ever, our data suggest that RNase MRP is not essential for ITS1 
processing and that a distinct endonuclease is responsible for 
site 2 cleavage in human cells.
It is not clear why endonucleolytic cleavage at site 2a is 
not part of the major processing pathway in humans. In yeast, sev-
eral pre-rRNA processing steps, including cleavage at A2, occur 
cotranscriptionally (Kos and Tollervey, 2010), whereas analyses 
likely suggests that other proteins, such as the Rex exonucle-
ases, also contribute to 21S 3 processing. Depletion of XRN2, 
which favors site 2a cleavage, can rescue 18SE production 
in the absence of the exosome or MTR4, indicating that the ma-
jority of rRNA is normally processed via this exonucleolytic 
pathway. In yeast, the A3 cleavage site is an entry point for 
Rrp6 (Allmang et al., 2000). Moreover, pre-rRNA deletions 
around site A2 do not block 18S synthesis (Allmang et al., 
1996), which is consistent with the possibility of alternative 
pathways in yeast that might more closely resemble human pre-
rRNA processing.
We found that SSU processome components are required 
for endonucleolytic cleavage at site 2a as is the case for site A2 
cleavage in yeast. Surprisingly, site 2a cleavage is part of the 
minor rRNA processing pathway. 36S rRNA, the only precur-
sor specific to this pathway, is rarely observed in a variety of 
human cell lines (HeLa, HEK293, TC7, and MCF7; unpublished 
data) and under different growth conditions, making it difficult 
to determine the fraction of pre-rRNA normally processed via 
endonucleolytic cleavage at 2a. As seen with the A2 cleavage 
in yeast, no precursors processed at 2a but still containing the 
5ETS sequence were observed, indicating that endonucleolytic 
cleavage at site 2a obligatorily occurs together with or after re-
moval of the 5ETS.
We found that site 2 cleavage in human cells was signifi-
cantly inhibited by depletion of RRP5, NOL12, BOP1, or to a 
lesser extent RBM28, suggesting that it is analogous to the 
A3 cleavage in yeast. Depletion of NOL12, RRP5, BOP1, and 
RBM28 also affected site 2a cleavage. However, as it is not 
known what percentage of transcripts are naturally processed at 
2a it is difficult to determine whether depletion of these proteins 
actually increases or decreases cleavage at this site. In the case 
of RRP5 depletion, both ITS1 cleavages could be bypassed, 
with primary cleavage occurring in ITS2. The observation that 
the putative exonuclease NOL12 is essential for both cleavages 
in ITS1 was particularly surprising. The 36SC pre-rRNA, seen 
after depletion of RBM28 or BOP1, is likely to be an intermediate 
Figure 7. Alternative processing pathways for human ITS1. Schematic representations of the yeast, human major, and human minor ITS1 processing pathways.
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labeled with -[32P]ATP using T4 polynucleotide kinase and used as probes. 
Random prime-labeled probes hybridizing immediately upstream and 
downstream of the A’ cleavage in the 5ETS (ETS1 and ETS2, respectively) 
were produced from PCR products (Turner et al., 2009). Random prime- 
labeled probes against the full-length RNase MRP RNA and the S domain 
of 7SL were also generated.
For metabolic labeling experiments using 3H methyl-methionine, 
the cells were incubated in methionine-free media (15 min) and then in 
methionine-free media containing 50 µCi/ml 3H-labeled methyl-methionine 
(30 min). The cells were then incubated in normal media containing 10× 
the normal concentration of methionine and harvested at the required time 
points (0, 15, 30, 60, 120, and 240 min). For metabolic labeling experi-
ments using 32P orthophosphate, cells were grown in phosphate-free media 
(1 h) followed by phosphate-free media containing 15 µCi/ml 32P-labeled 
inorganic phosphate (1 h). Cells were then incubated in normal media and 
harvested at the required time points (0, 30, 60, 120, and 240 min). RNA 
was extracted using TRI reagent and analyzed by agarose-glyoxal or urea-
PAGE as appropriate. Results were visualized using a phosphorimager 
(Typhoon FLA9000; GE Healthcare). All quantitation was normalized to 
the levels of mature 18S or 28S rRNA, as appropriate.
Immunofluorescence
HEK293 cells expressing either the FLAG tag only (pcDNA5 [Knox et al., 
2011]), FLAG-RRP6, or FLAG-tagged, RNAi-resistant RRP6 or RRP6exo 
were grown on coverslips and induced with 0.1 mg/ml tetracycline for 
36 h before being fixed with PBS containing 4% paraformaldehyde. 
The cells were washed with PBS and permeabilized in 0.2% Triton X-100 
and then blocked in PBS/10% FCS. Cells were incubated with the 
anti-FLAG (rabbit; Sigma-Aldrich) and anti-fibrillarin (72B9; mouse) in 
PBS/10% FCS. Cells were washed with PBS and then incubated with the 
secondary antibody (Alexa Fluor 555–labeled donkey anti–mouse and 
Alexa Fluor 647–labeled donkey anti–rabbit) in PBS/10% FCS. The cells 
were washed with PBS containing DAPI and then mounted in Mowiol. All 
steps were performed at room temperature. Images were captured with an 
inverted microscope (Axiovert 200M; Carl Zeiss) with a Plan-Apochromat, 
100×/1.40 oil DIC ×/0.17 objective (Carl Zeiss) and an AxioCam HRm 
camera, using Axiovision software.
Online supplemental material
Fig. S1 shows Northern blot ITS1 mapping data. Fig. S2 shows RNAi de-
pletion of ribosome biogenesis factors from HeLa cells. Fig. S3 is a charac-
terization of HEK293 stable cells lines expressing RRP6. Fig. S4 shows the 
requirement for SSU proteins and RNase MRP/P subunits in the formation 
of the mature rRNAs. Fig. S5 is a model of human ITS1 structure. Table S1 
shows ribosome biogenesis factor siRNA sequences. Table S2 contains 
the antibodies used in this study. Table S3 shows the primers used to 
make RRP6 expression constructs. Table S4 shows Northern blot probe 
sequences. Online supplemental material is available at http://www.jcb 
.org/cgi/content/full/jcb.201207131/DC1.
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